Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > I forgot that…

<< Previous

Bullboard Posts

Next >>

Comment by BayStreetWildon Aug 16, 2021 10:55am

92 Views

Post# 33709745

RE:RE:RE:I forgot that…

credibility? What's that?

BayStreetWild wrote:

there's been a lot of implying but not a lot of delivering. Check the latest presentation. Cleveland clinic was supposed to have patient enrolment started July 18. The remaining 2 LSHU and U Arkansas were supposed to be up and running Aug 13. Didn't see that in the new update. Just words on paper.

It would be nothing short of a miracle for 10+ to be enrolled per month. So far the number is substantially less than 1 per month so it's not even realistic at this point.

When you say Kellum has got it back to 10+ per month, what do you mean? It has never in the history of Tigris been 10 so how would it "go back"? That's quite misleading of you.

mercedesman wrote:

BayStreetWild wrote: At this enrolment rate the market is pricing in a multi year delay. 20 people in 36 months? Ouch.

Are you suggesting that once it is announced that Kellum has got the enrollment back up to 10+ per month (as implied in recent discussions/releases) that the stock will quickly get re-priced higher? Especially since that would imply interim data targets (90) being achieved as early as this coming Feb or March - and not a further multi-year delay that you seem to imply is the current market expectation?

Just asking becasue I'm trying to gauge how much longer I have to complete my buying at these levels (20-25% below Be-all's insider $200k investmnent, and the other insider's recent Unit grab). I feel that a 20-25% discount off unit price makes up for the 15 % dilution - assuming you have the conviction - like insiders seem to have, and all those 45 cent warrant holders a few months prior to that.

Perhaps not a fair question to you, as I suppose the timing of the snap back somewhat depends on how many more "weak hand" shares need to be jettisoned in the line of duty. Not to mention the recent shorting exercise. I heard it from a guy, who heard it from a guy, who heard it from a guy, that as of last week there was a couple of million shares left to be sold. In reality, it's hard to say how much is left to go, when there is always a good chunk traded on the dark pools.

MM